Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide. 2007

Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
Department of Oncology, Royal Free and University College Medical School, University College London, 91 Riding House Street, London W1W 7BS, United Kingdom. d.hochhauser@ucl.ac.uk

Topoisomerase IIalpha (topo IIalpha) is an important target for several chemotherapeutic agents, including etoposide and doxorubicin. Confluent cells express low levels of topo IIalpha and are resistant to etoposide treatment. Repression of transcription in confluent cells is mediated by binding of the transcription factor NF-Y to inverted CCAAT motifs within the topo IIalpha promoter. To block the repressive binding of NF-Y, a polyamide (JH-37) was designed to bind to the flanking regions of selected CCAAT sites within the topo IIalpha promoter. Electrophoretic mobility shift assays and DNase I footprinting assays showed occupancy of the inverted CCAAT sites by JH-37. Chromatin immunoprecipitation assays confirmed in vivo inhibition of NF-Y binding to the topo IIalpha promoter. Following incubation of confluent NIH3T3 cells with JH-37, increased expression of topo IIalpha mRNA and protein was detectable. This correlated both with increased DNA double-strand breaks as shown by comet assay and decreased cell viability following exposure to etoposide. Polyamides can modulate gene expression and chemosensitivity of cancer cells.

UI MeSH Term Description Entries
D009757 Nylons Polymers where the main polymer chain comprises recurring amide groups. These compounds are generally formed from combinations of diamines, diacids, and amino acids and yield fibers, sheeting, or extruded forms used in textiles, gels, filters, sutures, contact lenses, and other biomaterials. Polyamides,Dermalon,Ethilon,Nylon,Polyamide,Supramid,Dermalons,Ethilons,Supramids
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
January 2000, Cell biochemistry and biophysics,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
September 2001, Journal of the American Chemical Society,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
January 2002, Anticancer research,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
October 1998, Cancer research,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
April 2000, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
May 2000, The Journal of biological chemistry,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
June 2007, Proceedings of the National Academy of Sciences of the United States of America,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
February 2002, European journal of cancer (Oxford, England : 1990),
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
August 2001, Cell structure and function,
Daniel Hochhauser, and Minal Kotecha, and Caroline O'hare, and Peter J Morris, and Janet M Hartley, and Zarmeen Taherbhai, and Dorothy Harris, and Claudia Forni, and Roberto Mantovani, and Moses Lee, and John A Hartley
April 2001, Toxicology letters,
Copied contents to your clipboard!